Health Care Stocks

Drug makers, biotechnology, medical devices, laboratory instruments, health insurers and hospitals. 185 companies worth $6.7T together, at a median P/E of 25.7.

Pharmaceutical Preparations

Largest first.

Company	Market value	P/E	Yield	From 52-week high	Short interest
Eli Lilly and CoLLYPharmaceutical Preparations	$1.1T$1,179.27	41.6×	0.6%	-7.9%	0.7%
Johnson & JohnsonJNJPharmaceutical Preparations	$630B$261.44	29.9×	2.0%	-6.1%	0.9%
AbbVie IncABBVPharmaceutical Preparations	$488.6B$276.47	77.4×	2.5%	0.0%	0.9%
Merck & Co IncMRKPharmaceutical Preparations	$359.2B$145.60	113.2×	2.3%	-6.9%	1.1%
Abbott LaboratoriesABTPharmaceutical Preparations	$174B$99.60	27.7×	2.5%	-25.3%	0.8%
Pfizer IncPFEPharmaceutical Preparations	$161.2B$28.28	37.2×	6.1%	-2.5%	2.6%
Vertex Pharmaceuticals IncVRTXPharmaceutical Preparations	$129.2B$510.08	29.3×	—	-8.6%	1.8%
Bristol-Myers Squibb CoBMYPharmaceutical Preparations	$120.8B$59.12	13.0×	3.2%	-13.2%	2.2%
Regeneron Pharmaceuticals IncREGNPharmaceutical Preparations	$79.1B$746.54	18.3×	0.5%	-12.4%	2.0%
Teva Pharmaceutical Industries LtdTEVAPharmaceutical Preparations	$47.9B$41.10	67.8×	—	0.0%	2.6%
Alnylam Pharmaceuticals IncALNYPharmaceutical Preparations	$31.1B$232.68	99.2×	—	-52.6%	5.8%
Zoetis IncZTSPharmaceutical Preparations	$31B$74.81	11.8×	2.8%	-49.3%	4.4%
Roivant Sciences LtdROIVPharmaceutical Preparations	$25.6B$35.44	—	—	-15.2%	5.4%
United Therapeutics CorpUTHRPharmaceutical Preparations	$23.4B$549.16	17.9×	—	-8.0%	8.4%
Insmed IncINSMPharmaceutical Preparations	$22B$100.60	—	—	-52.4%	6.3%
Viatris IncVTRSPharmaceutical Preparations	$20.3B$17.64	—	2.7%	-3.4%	3.7%
Jazz Pharmaceuticals PLCJAZZPharmaceutical Preparations	$14.2B$218.42	15.1×	—	-16.5%	8.4%
BridgeBio Pharma IncBBIOPharmaceutical Preparations	$12.8B$65.35	—	—	-27.5%	10.1%
Elanco Animal Health IncELANPharmaceutical Preparations	$11.4B$22.92	—	—	-14.6%	7.5%
Madrigal Pharmaceuticals IncMDGLPharmaceutical Preparations	$10.9B$471.75	—	—	-21.7%	10.4%
BioMarin Pharmaceutical IncBMRNPharmaceutical Preparations	$10.6B$54.80	145.3×	—	-22.0%	6.0%
Arrowhead Pharmaceuticals IncARWRPharmaceutical Preparations	$8.9B$62.75	—	—	-30.0%	7.6%
Axsome Therapeutics IncAXSMPharmaceutical Preparations	$8.8B$168.35	—	—	-34.0%	6.3%
Cytokinetics IncCYTKPharmaceutical Preparations	$8.7B$62.91	—	—	-27.9%	13.9%
Ionis Pharmaceuticals IncIONSPharmaceutical Preparations	$7.5B$45.28	—	—	-47.7%	13.6%
Praxis Precision Medicines IncPRAXPharmaceutical Preparations	$7.3B$259.86	—	—	-32.7%	15.0%
Alkermes PlcALKSPharmaceutical Preparations	$6.8B$40.61	102.9×	—	-26.5%	10.6%
Ligand Pharmaceuticals IncLGNDPharmaceutical Preparations	$6B$301.81	30.5×	—	-6.4%	13.4%
Structure Therapeutics IncGPCRPharmaceutical Preparations	$5.5B$25.54	—	—	-72.8%	3.5%
Cogent Biosciences IncCOGTPharmaceutical Preparations	$5.3B$31.00	—	—	-27.6%	11.3%
Organon & CoOGNPharmaceutical Preparations	$3.6B$13.81	17.4×	0.6%	0.0%	7.2%
ACADIA Pharmaceuticals IncACADPharmaceutical Preparations	$3.4B$19.78	8.9×	—	-35.3%	4.8%
Arcutis Biotherapeutics IncARQTPharmaceutical Preparations	$3.3B$26.58	117.1×	—	-14.8%	17.3%
Amylyx Pharmaceuticals IncAMLXPharmaceutical Preparations	$3.1B$28.14	—	—	-29.0%	11.4%
Supernus Pharmaceuticals IncSUPNPharmaceutical Preparations	$2.5B$42.67	—	—	-25.1%	8.6%
Bausch Health Companies IncBHCPharmaceutical Preparations	$2.3B$6.04	—	—	-23.5%	2.2%
Agios Pharmaceuticals IncAGIOPharmaceutical Preparations	$1.9B$31.81	—	—	-30.1%	11.8%
Sarepta Therapeutics IncSRPTPharmaceutical Preparations	$1.9B$17.85	—	—	-27.0%	21.6%
Compass Pathways PLCCMPSPharmaceutical Preparations	$1.6B$12.00	—	—	-21.0%	12.6%
Innoviva IncINVAPharmaceutical Preparations	$1.5B$21.21	4.3×	—	-12.5%	9.4%
Ultragenyx Pharmaceutical IncRAREPharmaceutical Preparations	$1.5B$15.48	—	—	-57.6%	20.6%
Pacira Biosciences IncPCRXPharmaceutical Preparations	$1.4B$36.31	98.8×	—	-0.2%	20.3%
Maravai LifeSciences Holdings IncMRVIPharmaceutical Preparations	$1.1B$7.44	—	—	-17.3%	9.3%
OPKO Health IncOPKPharmaceutical Preparations	$1B$1.38	—	—	-20.2%	4.8%
Kura Oncology IncKURAPharmaceutical Preparations	$942.9M$10.60	—	—	-22.0%	16.2%
Theravance Biopharma IncTBPHPharmaceutical Preparations	$883.7M$17.03	16.4×	—	-17.9%	—
Cryoport IncCYRXPharmaceutical Preparations	$878.8M$17.35	11.2×	—	-4.4%	4.7%
Nektar TherapeuticsNKTRPharmaceutical Preparations	$839M$41.17	—	—	-59.0%	34.2%
Puma Biotechnology IncPBYIPharmaceutical Preparations	$525.8M$10.29	19.7×	—	0.0%	8.3%
Enanta Pharmaceuticals IncENTAPharmaceutical Preparations	$364M$12.50	—	—	-25.8%	8.8%
Emergent BioSolutions IncEBSPharmaceutical Preparations	$362.2M$7.06	6.9×	—	-49.2%	18.1%
Relmada Therapeutics IncRLMDPharmaceutical Preparations	$361.6M$3.39	—	—	-56.9%	12.6%
Oramed Pharmaceuticals IncORMPPharmaceutical Preparations	$178.9M$4.33	2.8×	5.8%	-18.9%	3.5%
TuHURA Biosciences IncHURAPharmaceutical Preparations	$124.8M$1.96	—	—	-37.8%	9.6%
Inovio Pharmaceuticals IncINOPharmaceutical Preparations	$94.7M$1.15	—	—	-55.8%	25.3%
Heron Therapeutics IncHRTXPharmaceutical Preparations	$77.8M$0.41	—	—	-72.5%	24.2%
NanoViricides, IncNNVCPharmaceutical Preparations	$29.9M$1.30	—	—	-36.0%	4.0%
Revelation Biosciences IncREVBPharmaceutical Preparations	$3M$0.76	—	—	-86.0%	0.0%
Aptevo Therapeutics IncAPVOPharmaceutical Preparations	$2.5M$1.79	—	—	-93.9%	8.4%
Genprex IncGNPXPharmaceutical Preparations	$1.4M$2.72	—	—	-99.7%	19.2%
Sunshine Biopharma IncSBFMPharmaceutical Preparations	$807.3K$0.34	—	—	-98.5%	5.5%

Industries are the SEC's own codes for each company. Market value is the latest close times the shares on the latest filing; P/E is left out where earnings are not positive.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.Institutional HoldingsWhich funds own these companies, and what they changed.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.